Clinical characteristics of mephedrone toxicity reported to the U.K. National Poisons Information Service
- PMID: 20798084
- PMCID: PMC3143586
- DOI: 10.1136/emj.2010.096636
Clinical characteristics of mephedrone toxicity reported to the U.K. National Poisons Information Service
Abstract
Objective: To describe the patterns and clinical features of toxicity related to recreational use of mephedrone and other cathinones in the U.K. using data collected by the National Poisons Information Service (NPIS).
Methods: The number of accesses to TOXBASE, the NPIS online poisons information database, details of consecutive cases uploaded onto TOXBASE and the number and details of telephone enquiries made to the NPIS by health professionals in the U.K. were collected for the period March 2009 to February 2010.
Results: Over the year of study there were 2901 TOXBASE accesses and 188 telephone enquiries relating to cathinones, the majority relating to mephedrone (TOXBASE 1664, telephone 157), with a month-on-month increase in numbers. In 131 telephone enquiries concerning mephedrone, alone or in combination with alcohol, common clinical features reported included agitation or aggression (n=32, 24%, 95% CI 18% to 33%), tachycardia (n=29, 22%, 95% CI 16% to 30%), confusion or psychosis (n=18, 14%, 95% CI 9% to 21%), chest pain (n=17, 13%, 95% CI 8% to 20%), nausea (n=15, 11%, 95% CI 7% to 18%), palpitations (n=14, 11%, 95% CI 6% to 18%), peripheral vasoconstriction (n=10, 8%, 95% CI 4% to 14%) and headache (n=7, 5%, 95% CI 2% to 11%). Convulsions were reported in four cases (3%, 95% CI 1% to 8%). One exposed person died following cardiac arrest (1%, 95% CI 0% to 4%), although subsequent investigation suggested that mephedrone was not responsible.
Conclusions: Toxicity associated with recreational mephedrone use is increasingly common in the UK. Sympathomimetic adverse effects are common and severe effects are also reported. Structured data collected by the NPIS may be of use in identifying trends in poisoning and in establishing toxidromes for new drugs of abuse.
Conflict of interest statement
Figures
Similar articles
-
Patterns of presentation and clinical features of toxicity after reported use of ([2-aminopropyl]-2,3-dihydrobenzofurans), the 'benzofuran' compounds. A report from the United Kingdom National Poisons Information Service.Clin Toxicol (Phila). 2014 Dec;52(10):1025-31. doi: 10.3109/15563650.2014.973115. Epub 2014 Oct 27. Clin Toxicol (Phila). 2014. PMID: 25345418
-
Effect of the UK Psychoactive Substances Act 2016 on episodes of toxicity related to new psychoactive substances as reported to the National Poisons Information Service. A time series analysis.Int J Drug Policy. 2020 Mar;77:102672. doi: 10.1016/j.drugpo.2020.102672. Epub 2020 Feb 4. Int J Drug Policy. 2020. PMID: 32032867
-
Epidemiology and clinical features of toxicity following recreational use of synthetic cannabinoid receptor agonists: a report from the United Kingdom National Poisons Information Service.Clin Toxicol (Phila). 2016 Jul;54(6):512-8. doi: 10.3109/15563650.2016.1171329. Epub 2016 Apr 19. Clin Toxicol (Phila). 2016. PMID: 27091041
-
Using poisons information service data to assess the acute harms associated with novel psychoactive substances.Drug Test Anal. 2014 Jul-Aug;6(7-8):850-60. doi: 10.1002/dta.1671. Epub 2014 May 15. Drug Test Anal. 2014. PMID: 24832864 Review.
-
Mephedrone concentrations in clinical intoxications and fatal cases: a systematic review.Forensic Toxicol. 2025 Jan;43(1):46-61. doi: 10.1007/s11419-024-00693-1. Epub 2024 Jul 20. Forensic Toxicol. 2025. PMID: 39031238
Cited by
-
Neurotoxicity of methamphetamine and 3,4-methylenedioxymethamphetamine.Life Sci. 2014 Feb 27;97(1):37-44. doi: 10.1016/j.lfs.2013.07.014. Epub 2013 Jul 24. Life Sci. 2014. PMID: 23892199 Free PMC article. Review.
-
Epigenetic Studies for Evaluation of NPS Toxicity: Focus on Synthetic Cannabinoids and Cathinones.Biomedicines. 2022 Jun 13;10(6):1398. doi: 10.3390/biomedicines10061398. Biomedicines. 2022. PMID: 35740419 Free PMC article. Review.
-
Mephedrone, compared with MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and 5-HT levels in nucleus accumbens of awake rats.Br J Pharmacol. 2011 Dec;164(8):1949-58. doi: 10.1111/j.1476-5381.2011.01499.x. Br J Pharmacol. 2011. PMID: 21615721 Free PMC article.
-
Mephedrone inhalation causes pneumomediastinum.BMJ Case Rep. 2014 Mar 10;2014:bcr2014203704. doi: 10.1136/bcr-2014-203704. BMJ Case Rep. 2014. PMID: 24614784 Free PMC article.
-
Flakka: New Dangerous Synthetic Cathinone on the Drug Scene.Int J Mol Sci. 2020 Oct 31;21(21):8185. doi: 10.3390/ijms21218185. Int J Mol Sci. 2020. PMID: 33142953 Free PMC article. Review.
References
-
- Advisory Council on the Misuse of Drugs Consideration of the cathinones. 31 March 2010. http://drugs.homeoffice.gov.uk/publication-search/acmd/ACMD-cathinones-r... (accessed 1 Apr 2010).
-
- Winstock AR, Marsden J, Mitcheson L. What should be done about mephedrone? BMJ 2010;340:c1605. - PubMed
-
- Kamata HT, Shima N, Zaitsu K, et al. Metabolism of the recently encountered designer drug, methylone, in humans and rats. Xenobiotica 2006;36:709–23 - PubMed
-
- Markus R, Meyer MR, Wilhelm J, et al. Beta-keto amphetamines: studies on the metabolism of the designer drug mephedrone and toxicological detection of mephedrone, butylone, and methylone in urine using gas chromatography–mass spectrometry. Anal Bioanal Chem 2010;397:1225–33 - PubMed
-
- Glennon RA, Yousif MY, Naiman N, et al. Methcathinone: a new and potent amphetamine-like agent. Pharmacol Biochem Behav 1987;26:547–51 - PubMed